| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $399K | — | +72.0% |
| R&D Expense | $2K | — | +160.0% |
| SG&A Expense | $78K | — | +73.6% |
| Operating Income | -$77K | — | -246.5% |
| Net Income | -$288K | — | -119.9% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20K | +50.3% | -14.5% |
| Current Assets | $20K | +50.3% | -14.5% |
| Total Assets | $905K | +17.3% | +53.4% |
| Current Liabilities | $11.1M | +3.9% | +13.9% |
| Stockholders' Equity | -$10.2M | -2.8% | -11.4% |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$61K | — | -960.9% |
| Investing Cash Flow | -$127K | — | — |
| Financing Cash Flow | $194K | — | +3925.9% |